Rigorous science done transparently
THE FIRST MICRODOSING PSILOCYBIN FOR DEPRESSION STUDY
Our team conducted the world’s first and largest clinical trial on microdosing psilocybin in patients with Major Depression who have previously been unresponsive or unwilling to pursue standard treatment options for their depression.
The results of the study have been analyzed and are currently being published. For more information, scroll down to our research section or click here.
CONSULTING
Helping industry remain scientific and open
RESEARCH
The science of psychedelic microdosing
MICRODOSING PSILOCYBIN
Self-report measures shows that microdosing is associated with improved mood and enhanced well-being, however there is almost no scientific evidence for the effects of this practice. Our most recent preprint "Safety and Efficacy of Microdosing Psilocybin over 8 Weeks for Major Depressive Disorder: A Randomized Clinical Trial" showed that repeated low doses of psilocybin were safe and well tolerated in this population but did not produce a meaningful change in mood or symptom severity.
PUBLICATIONS
We have published some of the first academic research on psychedelic microdosing. Click on the publication link at the top of the page or on the document icon to the left to check them out. You can also scroll down to find media covering our research.
ROTEM PETRANKER
Co-Founder and Director
Rotem Petranker is a scientist-clinician. He is a postdoctoral fellow at the Centre for Health Innovation and Research in Psychedelics and a doctoral associate at the PsychoEd clinic. He co-founded the Canadian Centre for Psychedelic Science and the Psychedelic Studies Research Program at the University of Toronto. His main research interests are sustained attention, emotional regulation, and creativity, and his clinical interests include anxiety, ADHD, and OCD. Rotem advocates for establishing a rigorous framework for the study of psychedelics using the principles of Open Science.
THOMAS ANDERSON
Co-Founder and Director
Thomas Anderson is a PhD Candidate studying Cognitive Neuroscience at the University of Toronto (Toronto, Canada). Thomas is a strong proponent of Open Science and publicly communicating scientific findings. He has shared our research findings and presentations on ResearchGate to communicate about this research with the public.
ZEINA BEIDAS
Coordinator
Zeina Beidas graduated from the University of Toronto with an Honors Bachelor's degree in Neuropsychology & is an incoming Master's student in Counselling Psychology at the University Of Toronto. She has served as the lead clinical assistant on the microdosing trial for depression and continues to support CCPS initiatives. She is interested in the therapeutic use of psychedelics and in promoting their safe, transparent, and accessible use.
OUR TEAM
MEDIA
